Ginkgo Bioworks Holdings (DNA) Times Interest Earned (2020 - 2024)
Ginkgo Bioworks Holdings posted quarterly Times Interest Earned of -$3.3 for Q4 2024, up 18.4% year-on-year from -$2.79 in Q1 2024, and down 155.35% on a QoQ basis from $5.97 in Q3 2024.
Ginkgo Bioworks Holdings (DNA) has 4 years of Times Interest Earned data on file, last reported at -$3.3 in Q4 2024.
- For the quarter ending Q4 2024, Times Interest Earned rose 18.4% year-over-year to -$3.3; the trailing twelve-month figure through Sep 2025 stood at -$10.84 (up 58.21% YoY), and the FY2024 full-year result was -$5954.9, up 35.93% from the prior year.
- Times Interest Earned for Q4 2024 stood at -$3.3, down from $5.97 in the prior quarter.
- Across five years, Times Interest Earned topped out at $21.62 in Q2 2024 and bottomed at -$3057.6 in Q4 2021.
- The 4-year median for Times Interest Earned is -$3.68 (2023), against an average of -$319.94.
- The widest annual swing landed in 2021, when Times Interest Earned sank 3127.85%; it then soared 68.45% in 2024.
- A 4-year view of Times Interest Earned shows it stood at -$94.73 in 2020, then tumbled by 3127.85% to -$3057.6 in 2021, then soared by 99.87% to -$4.05 in 2023, then advanced by 18.4% to -$3.3 in 2024.
- The last three Times Interest Earned figures came in at -$3.3 (Q4 2024), $5.97 (Q3 2024), and $21.62 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -3.30 |
| Sep 30, 2024 | 5.97 |
| Jun 30, 2024 | 21.62 |
| Dec 31, 2023 | -4.05 |
| Sep 30, 2023 | 19.07 |
| Jun 30, 2023 | 12.83 |
| Dec 31, 2021 | -3,057.60 |
| Sep 30, 2021 | -41.10 |
| Dec 31, 2020 | -94.73 |
| Sep 30, 2020 | -58.13 |